Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Fadi A, Saab"'
Autor:
Anthony Pham, Cole Pollina, Anthony Bruccoliere, Ardalan Naghian, Geoff Thomas, Elwin Rutayomba, Steven Daley, Nitish Mittal, Mikal Ramon, Aliakbar Arvandi, Marina Iskandir, Mohammad M. Ansari, Dixon Santana, Sahil A. Parikh, Subhash Banerjee, Fadi A. Saab, Craig M. Walker
Publikováno v:
Journal of the Society for Cardiovascular Angiography & Interventions. 2:100941
Autor:
Fadi A. Saab, Jihad A. Mustapha, Mohammad Ansari, Guy Pupp, Kumar Madassery, Zola N’Dandu, Bret N. Wiechmann, Rick Bernstein, Abigail Mize, George Pliagas
Publikováno v:
Journal of the Society for Cardiovascular Angiography & Interventions. 1:100437
Publikováno v:
The Journal of invasive cardiology. 31(3)
To investigate the feasibility, safety, and effectiveness of the LimFlow stent-graft system in performing percutaneous deep vein arterialization (pDVA) for treatment of critical limb ischemia (CLI) patients ineligible for conventional endovascular or
Autor:
Fadi A. Saab
Publikováno v:
Cardiovascular Catheterization and Intervention ISBN: 9781315113869
Cardiovascular Catheterization and Intervention
Cardiovascular Catheterization and Intervention
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9de1e561751fa99660e8c4ab44d63a13
https://doi.org/10.1201/9781315113869-25
https://doi.org/10.1201/9781315113869-25
Autor:
Fadi A, Saab, Philippe Gabriel, Steg, Alvaro, Avezum, José, López-Sendón, Frederick A, Anderson, Wei, Huang, Kim A, Eagle
Publikováno v:
American heart journal. 160(5)
Coronary artery disease is the leading cause of death in women. We sought to validate previous clinical experience in which we have observed that elderly women with a very high left ventricular ejection fraction (LVEF) are at increased risk of death
Autor:
Fadi A, Saab, Mircea, Petrina, Eva, Kline-Rogers, Jianming, Fang, Richard, Otten, Debabrata, Mukherjee, Kim A, Eagle
Publikováno v:
Indian heart journal. 58(4)
Elderly patients are less likely to receive statin therapy because of concerns about their side-effects. However, 80% of deaths related to coronary heart disease occur in patients above the age of 65 years. This study evaluated the potential benefit